BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32980890)

  • 21. Successful treatment of a pregnant woman with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Nakajima Y; Kuwabara H; Hattori Y; Ohshima R; Sakai R; Kitagawa M; Tomita N; Ishigatsubo Y; Fujisawa S
    Int J Hematol; 2013 Mar; 97(3):427-9. PubMed ID: 23359302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterizing Iranian Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia Through Gene Expression Profiling of Common ATP Binding Cassette Transporters Subfamily C.
    Mehrvar N; Abolghasemi H; Rezvany MR; Akbari ME; Saberynejad J; Mehrvar A; Movafagh A
    J Pediatr Hematol Oncol; 2020 Jan; 42(1):41-45. PubMed ID: 31613845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
    Hann I; Vora A; Harrison G; Harrison C; Eden O; Hill F; Gibson B; Richards S;
    Br J Haematol; 2001 Apr; 113(1):103-14. PubMed ID: 11328289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood.
    Schmäh J; Fedders B; Panzer-Grümayer R; Fischer S; Zimmermann M; Dagdan E; Bens S; Schewe D; Moericke A; Alten J; Bleckmann K; Siebert R; Schrappe M; Stanulla M; Cario G
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and significance of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia.
    Piskunova IS; Obukhova TN; Parovichnikova EN; Kulikov SM; Troitskaya VV; Gavrilina OA; Savchenko VG
    Ter Arkh; 2018 Aug; 90(7):30-37. PubMed ID: 30701920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
    Park HS; Kim DY; Choi EJ; Lee JH; Lee JH; Jeon M; Kang YA; Lee YS; Seol M; Cho YU; Jang S; Chi HS; Lee KH; Park CJ
    Acta Haematol; 2018; 139(4):220-227. PubMed ID: 29860259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
    Chiu EK; Chan LC; Liang R; Lie A; Kwong YL; Todd D; Chan TK
    Leukemia; 1994 Sep; 8(9):1469-73. PubMed ID: 8090027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Initial response to therapy as an important prognostic factor in acute lymphoblastic leukemia in childhood. COALL study group].
    Janka-Schaub GE; Stührk H; Kortüm B; Graubner U; Jürgens H; Spaar HJ; Schöck V; Dohrn B; Bahr R; Winkler K
    Klin Padiatr; 1991; 203(4):231-5. PubMed ID: 1942930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy.
    Dworzak MN; Schumich A; Printz D; Pötschger U; Husak Z; Attarbaschi A; Basso G; Gaipa G; Ratei R; Mann G; Gadner H
    Blood; 2008 Nov; 112(10):3982-8. PubMed ID: 18780832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of outcome by early response in childhood acute lymphoblastic leukemia.
    Möricke A; Lauten M; Beier R; Odenwald E; Stanulla M; Zimmermann M; Attarbaschi A; Niggli F; Schrappe M
    Klin Padiatr; 2013 May; 225 Suppl 1():S50-6. PubMed ID: 23700057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.
    Valera ET; Scrideli CA; Queiroz RG; Mori BM; Tone LG
    Sao Paulo Med J; 2004 Jul; 122(4):166-71. PubMed ID: 15543372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study of daunorubicin-augmented hyper-CVAD induction chemotherapy for adults with acute lymphoblastic leukemia.
    Kim SY; Park JH; Yoon SY; Cho YH; Lee MH
    Cancer Chemother Pharmacol; 2018 Feb; 81(2):393-398. PubMed ID: 29294168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia.
    Morishita N; Tsukahara H; Chayama K; Ishida T; Washio K; Miyamura T; Yamashita N; Oda M; Morishima T
    Pediatr Blood Cancer; 2012 Jul; 59(1):83-9. PubMed ID: 22183914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: an Egyptian study.
    Farawela HM; Khorshied MM; Kassem NM; Kassem HA; Zawam HM
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1323-30. PubMed ID: 24804815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lim SN; Joo YD; Lee KH; Kim DY; Lee JH; Lee JH; Chi HS; Yun SC; Lee WS; Lee SM; Park S; Kim I; Sohn SK; Moon JH; Ryoo HM; Bae SH; Hyun MS; Kim MK; Kim HJ; Yang DH; Eom HS; Lee GW; Jung CW; Won JH; Kim H; Lee JH; Shin HJ; Jang DY
    Am J Hematol; 2015 Nov; 90(11):1013-20. PubMed ID: 26228525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.
    Vitale A; Guarini A; Ariola C; Meloni G; Perbellini O; Pizzuti M; De Gregoris C; Mettivier V; Pastorini A; Pizzolo G; Vignetti M; Mandelli F; Foà R
    Haematologica; 2007 Mar; 92(3):342-8. PubMed ID: 17339183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow biopsy in adult acute lymphoblastic leukemia: morphological characteristics and contribution to the study of prognostic factors.
    Thomas X; Le QH; Danaïla C; Lhéritier V; Ffrench M
    Leuk Res; 2002 Oct; 26(10):909-18. PubMed ID: 12163052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407.
    Salzer WL; Jones TL; Devidas M; Hilden JM; Winick N; Hunger S; Carroll WL; Camitta B; Dreyer ZE
    Pediatr Blood Cancer; 2012 Nov; 59(5):834-9. PubMed ID: 22488662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.